SouthState’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.74K Buy
11
+2
+22% +$1.1K ﹤0.01% 798
2026
Q2
$4.74K Sell
9
-3
-25% -$1.68K ﹤0.01% 808
2026
Q1
$6.74K Sell
12
-140
-92% -$89.8K ﹤0.01% 722
2025
Q4
$103K Sell
152
-4
-3% -$2.72K ﹤0.01% 378
2025
Q3
$100K Sell
156
-7
-4% -$4.25K ﹤0.01% 382
2025
Q2
$87.4K Sell
163
-19
-10% -$9.09K ﹤0.01% 438
2025
Q1
$76.4K Buy
+182
New +$79K ﹤0.01% 470
2024
Q2
– Sell
-208
Closed -$112K – 704
2024
Q1
$112K Buy
+208
New +$114K 0.01% 290
2022
Q1
– Sell
-4
Closed -$3K – 737
2021
Q4
$3K Buy
+4
New +$2.51K ﹤0.01% 661

Other funds holding IDXX

SouthState's IDXX Position: Q3 2026 in Review

SouthState increased its Idexx Laboratories (IDXX) stake by 22% in Q3 2026, buying an estimated $1.1K and bringing the position to 11 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

SouthState first reported a position in IDXX in Q4 2021 and has held it in 9 quarters since. The position peaked at $112K in Q1 2024. 1,091 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • SouthState held 11 shares of Idexx Laboratories worth $5.74K as of Q3 2026.
  • SouthState bought 2 Idexx Laboratories shares in Q3 2026, an estimated $1.1K.
  • Idexx Laboratories made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #798 holding.
  • SouthState first reported a position in Idexx Laboratories in Q4 2021 and has held it in 9 quarters since.
  • SouthState's Idexx Laboratories position peaked at $112K in Q1 2024.
  • 1,091 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.